BEUDAMED
    FDA Adverse Event Injury Summary report: N

    GLUCOCARD EXPRESSION BLOOD GLUCOSE TEST SYSTEM

    MDR report key: 11639863 · Received April 9, 2021

    Report

    Report Number
    9616936-2021-00002
    Event Type
    Injury
    Date Received
    April 9, 2021
    Date of Event
    March 13, 2021
    Report Date
    March 15, 2021
    Manufacturer
    APEX BIOTECHNOLOGY CORP.
    Product Code
    NBW
    UDI-DI
    00015482570057
    PMA / PMN Number
    K113098
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    AL, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    INFORMATION PROVIDED BY IMPORTER ((B)(6) (UPDATED): 1. CUSTOMER RETURNED METER AND ONE TEST STRIP OF SPECIFIED LOT. THE RETURNED METER WAS TESTED WITH ONE TEST STRIP OF SPECIFIED LOT AND RETAIN STRIPS OF SPECIFIED LOT AND BLOOD PASSED TESTING. NO FAILURE DETECTED. METER WILL BE RETURNED TO THE MANUFACTURER FOR FURTHER INVESTIGATION. MANUFACTURE NARRATIVE (UPDATED): 1. THE COMPLAINED METER AND EMPTY TEST STRIP BOTTLE OF SPECIFIED LOT ARE RECEIVED ON (B)(6) 2021. 2. INVESTIGATION RESULTS OF THE RETURNED METER, INCLUDING FUNCTIONAL TEST, ARE NORMAL. PLEASE REFER TO ATTACHMENT 1 FOR DETAILS. 3. IN-HOUSE CLINICAL CAPILLARY BLOOD TEST (FINGER TIP BLOOD TEST) FOR THE RETURNED METER AND RETAIN METER WITH THE SPECIFIC LOT OF RETAIN TEST STRIPS IS CONDUCTED. THE RESULTS OF BOTH METERS ARE PASSED WITH THE SPECIFICATION. 4. ADDITIONAL MIOSTURE TEST TO THE DESICCANT IN RETURNED TEST STRIP BOTTLE IS PERFORMED AND THE RESULT IS UNACCEPTABLE. PLEASE REFER TO ATTACHMENT 4 FOR DETAILS. 5. THE POSSIBLE CAUSES OF THIS ADVERSE EVENT : (1) TEST STRIPS WERE STORING IN IMPROPER ENVIRONMENT; (2) TEST STRIP BOTTLE HAD NOT BEEN CLOSED IMMEDIATELY OR TIGHTLY AFTER TAKING OUT TEST STRIPS; BOTH CAUSES WILL LEAD TO INVALID DESICCANT AND FAILURE OF TEST STRIPS PERFORMANCE.

    Description of Event or Problem · 0

    PATIENT SAID SHE TOOK A READING AND RECEIVED 120, AND THEN TOOK ANOTHER READING AND RECEIVED 300. THESE READINGS WERE WITHIN 10 MINUTES. THIS OCCURRED SATURDAY, (B)(6) 2021 IN THE EVENING. SHE SAID SHE DIDN'T HAVE ANY SYMPTOMS. SHE THOUGHT SHE WAS OKAY. SHE DIDN'T EAT ANYTHING TO HELP LOWER HER BLOOD SUGAR. SHE DIDN'T TAKE ANY INSULIN. SHE DIDN'T HAVE ANY FOOD, BEVERAGES, OR MEDICINE TWO HOURS PRIOR. LATER, SHE WENT TO SLEEP LATER FOR A WHILE. HER HUSBAND TRIED TO WAKE HER UP, BUT SHE WASN'T RESPONDING TO HIM. HER HUSBAND CALLED THE PARAMEDICS AROUND 3 OR 4 AM. SHE SAID THE PARAMEDICS USED THEIR METER TO TEST HER GLUCOSE AND THEY RECEIVED 42. THEY GAVE HER SOMETHING TO HELP INCREASE HER GLUCOSE. SHE STARTED TO COME BACK TO HER NORMAL SELF AFTER THEY TREATED HER. SHE STORES METER IN HER BEDROOM. CUSTOMER IS NOT RECEIVING OXYGEN THERAPY. SHE DOESN'T HAVE TROUBLE GETTING A SAMPLE OF BLOOD AND SEALS STRIP BOTTLE TIGHTLY AND IMMEDIATELY AFTER OPENING. USES FINGERTIP AS A TESTING SITE. USES ALCOHOL TO CLEANSE TESTING SITE AND ALLOWS HANDS TO DRY THOROUGHLY. OPENED TEST STRIP BOTTLE LAST MONTH. VERIFIED THERE'S NO CHANGES IN DIET, EXERCISE OR STRESS LEVELS. VERIFIED SHE CHANGE THE LANCET EVERY TIME SHE TESTS. NORMAL GLUCOSE RANGE IS ABOUT 90-150.

    Additional Manufacturer Narrative · 1

    INFORMATION PROVIDED BY IMPORTER ((B)(4)): COMPLAINED PRODUCTS WERE NOT RETURNED FOR EVALUATION. RETAIN STRIPS OF SPECIFIED LOT WERE TESTED WITH REFERENCE METER AND PASSED TESTING WITH NO FAILURES DETECTED. IF EITHER METER OR STRIPS IS RETURNED, (B)(4) (THE IMPORTER) WILL EVALUATE THE PRODUCT AND FILE A FOLLOW-UP REPORT. MANUFACTURER NARRATIVE: IN-HOUSE CLINICAL CAPILLARY BLOOD TEST (FINGER TIP BLOOD TEST) FOR THE RETAIN METER AND THE SAME LOT OF RETAIN STRIPS IS CONDUCTED. THE RESULTS ARE PASSED WITH SPECIFIED SPECIFICATION. ROOT CAUSE OR POSSIBLE REASON FOR THIS COMPLAINT HAS NOT BEEN IDENTIFIED. IF THE COMPLAINED METER OR STRIPS RETURNED FROM THE USER THOUGHT THE IMPORTER, WE, APEX BIOTECHNOLOGY CORP. (THE MANUFACTURER) WILL EVALUATE THE PRODUCT AND FILE A FOLLOW-UP REPORT.

    Description of Event or Problem · 1

    PATIENT SAID SHE TOOK A READING AND RECEIVED 120, AND THEN TOOK ANOTHER READING AND RECEIVED 300. THESE READINGS WERE WITHIN 10 MINUTES. THIS OCCURRED SATURDAY, (B)(6) 2021 IN THE EVENING. SHE SAID SHE DIDN'T HAVE ANY SYMPTOMS. SHE THOUGHT SHE WAS OKAY. SHE DIDN'T EAT ANYTHING TO HELP LOWER HER BLOOD SUGAR. SHE DIDN'T TAKE ANY INSULIN. SHE DIDN'T HAVE ANY FOOD, BEVERAGES, OR MEDICINE TWO HOURS PRIOR. LATER, SHE WENT TO SLEEP LATER FOR A WHILE. HER HUSBAND TRIED TO WAKE HER UP, BUT SHE WASN'T RESPONDING TO HIM. HER HUSBAND CALLED THE PARAMEDICS AROUND 3 OR 4 AM. SHE SAID THE PARAMEDICS USED THEIR METER TO TEST HER GLUCOSE AND THEY RECEIVED 42. THEY GAVE HER SOMETHING TO HELP INCREASE HER GLUCOSE. SHE STARTED TO COME BACK TO HER NORMAL SELF AFTER THEY TREATED HER. SHE STORES METER IN HER BEDROOM. CUSTOMER IS NOT RECEIVING OXYGEN THERAPY. SHE DOESN'T HAVE TROUBLE GETTING A SAMPLE OF BLOOD AND SEALS STRIP BOTTLE TIGHTLY AND IMMEDIATELY AFTER OPENING. USES FINGERTIP AS A TESTING SITE. USES ALCOHOL TO CLEANSE TESTING SITE AND ALLOWS HANDS TO DRY THOROUGHLY. OPENED TEST STRIP BOTTLE LAST MONTH. VERIFIED THERE'S NO CHANGES IN DIET, EXERCISE OR STRESS LEVELS. VERIFIED SHE CHANGE THE LANCET EVERY TIME SHE TESTS. NORMAL GLUCOSE RANGE IS ABOUT 90-150.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    538085 GLUCOCARD EXPRESSION BLOOD GLUCOSE TEST SYSTEM GLUCOCARD EXPRESSION BLOOD GLUCOSE TEST SYSTEM NBW APEX BIOTECHNOLOGY CORP. 571100 B4S1907012 00015482570057

    Patients

    Seq Age Sex Outcome Treatment
    1 64 YR Life Threatening| R